Background: Complementary and alternative medicine (CAM) has become increasingly high profile in prosperous countries over the past 2 decades. Alongside this has been a renewed interest in the use of traditional medicine (TM) in poorer countries. Academic attention has tended to focus on either CAM in rich countries or indigenous TM in poorer ones. However, such a differentiation leads to a potential to gloss over global complexities, such as the study of countries where both CAM and TM are a potentially significant part of health options. Brazil is just such a country. Brazil is marked by massive socioeconomic inequalities; cancer is its second highest cause of death. To date, there has been little research on CAM/TM in cancer care in Brazil. Purpose: The purpose of this study is to provide the first exploratory data on the proportion of the use of CAM and/or TM among low-income cancer service users in Brazil. Method: A survey of cancer patients was conducted in November 2004 in a public-sector hospital in a major city in Brazil. A random sample (n = 92) was generated from a list of all appointments scheduled during that month (n = 570). Eighty-nine of the 92 patients contacted (97%) completed the questionnaire. Results: Of the sample, 62.9% had used at least 1 form of CAM or TM. However, this headline figure is potentially misleading. The data reveal an almost total absence of use of nonindigenous international CAM; it also shows prayer to be a major contributor to the relatively high use rate. Discussion: On the basis of this small-scale exploratory study, there is no evidence that those international CAMs ubiquitous in the West are spreading to low-income cancer service users in Brazil (despite anecdotal evidence of its increasing presence in the country generally). Moreover, when excluding prayer, use of indigenous traditional medicine was found to be relatively low. Further research is needed to examine these findings on a larger scale and to explore the relative importance of social, cultural, and economic factors behind them.
Complementary and alternative medicine (CAM) has become increasingly high profile over the past 2 decades across prosperous countries. 1 There is strong evidence of its popularity among users, 2 and despite evidence of conflicting positions among orthodox practitioners, 3 integration into the mainstream is a hot topic among policy makers and academics alike. 4 Focusing largely on the importation of the "exotic" into late/postmodern societies, 5 a sociology of CAM is developing. It has produced empirical and theoretical work on CAM as consumption, 6 professionalization processes, 7 demarcation disputes, 8 CAM globalization, 9 and the intersection of social worlds. 10 Alongside this West-oriented sociology of CAM has been a renewed interest in the role of traditional medicine (TM) in poorer countries. As well as being a longstanding element of anthropological research, 11 TM in poorer countries has achieved a higher profile through a World Health Organization report 12 examining the potential of non-Western approaches to health care.
Academic attention has thus tended to focus either on globalized CAM (those therapies and practicesreflexology, aromatherapy, etc-that have become ubiquitous across prosperous countries) as a feature of late/postmodern societies or on TM, non-Western approaches largely indigenous to the (poorer) country of use. However, this differentiation that has evolved in research has resulted in an oversimplification of a complex global situation. For instance, richer countries have their own traditional practices, and there is some evidence that globalized CAM is reaching even the poorest countries. 13 Furthermore, this concentration on global extremes has produced research unable to make sense of processes in many (difficult to classify) countries that fall between these extremes, countries that combine substantial individual wealth and Western-influenced cultural processes with widespread poverty and health inequality; countries where it is probable that both globalized CAM and TM have a role and where both intersect with orthodox provision. Brazil provides an excellent example of such a country.
Brazil is, geographically, the world's 5th largest country and has 170 million inhabitants. It is the 12th richest, yet 9.9% of its population live on less than US $1 a day. 14 It is marked by regional, class, ethnic, gender, and rural/urban inequalities 14 ; 83% of the population depend on state health provision, but more than half of health expenditure is private. 15 There is a long history of indigenous TM use, and the incorporation of globalized CAM among some groups is well advanced. 16 Health care is currently high profile in Brazil; recent government-led initiatives are producing policies favoring primary health care over technologydependent hospitals. 17 As part of this, the greater integration of CAM/TM into state provision is under active consideration, not least as a recognition of culturally diverse practices of Brazil's different ethnic groups.
Cancer is Brazil's second highest cause of death. 18 There are long waits for treatment; late treatment is a major contributory factor to mortality rates. 18 There is very little research on CAM/TM use in cancer care in Brazil, although a recent study supports anecdotal evidence about its high level of use (63% of patients). 19 There is currently no research specifically with low-income participants and no studies that differentiate between, on one hand, TM use and, on the other, use of globalized CAMs.
The aim of this study was to provide the first exploratory evidence about the proportion of the use of various TM/CAMs among low-income service users in Brazil. One particularly important issue is the extent to which nonindigenous CAMs are becoming part of a pluralistic health menu alongside or, indeed, instead of local traditional medicines. As the first study of its kind, the work is explicitly exploratory and was designed to inform larger scale and more in-depth research in the future.
Method
A survey of cancer patients was conducted at at a public-sector hospital attached to a major research university in a city in the southeast of Brazil. Ethics approval was sought and received. A random sample was generated (using the Epi-Info system) from the total number of people scheduled for appointments over a single month (570). For the calculation of the sample size, we began with the proportion of 50% of CAM use, an α error of 5%, and a variability in proportion of ±10% (ie, the proportion must be between 40% and 60%), with 10% possible refusal. This resulted in a total sample size of 92. Participants were required to be 18 years and older; exclusion was based on evident physical or mental distress.
The questionnaire was administered by a field researcher who had been fully trained in its use. Throughout November 2004, he attended the chemotherapy service at the hospital (both AM and PM sessions) to meet the selected patients. Patients were approached, and the study was explained to them to seek informed consent. Only 3 of the original 92 patients were not found or refused to cooperate; therefore, 89 patients participated. Four people answered the questionnaire over the telephone; all of the others were questioned personally. In all cases, the researcher rather than the participant completed the questionnaire, thereby avoiding the exclusion of those unable to read and write.
Results

Sample Characteristics
Eighty-nine participants took part in the study. Thirty-three (37.1%) were female, and 56 (62.9%) were male. This imbalance was a reflection of the study hospital's proximity to a women's hospital that also treated cancer. The median age was 60 years; 56 participants were white (62.9%), 4 were black (4.5%), and 29 were of mixed race (32.6%). Respondents had a median of 4 years of schooling; 13 people (14.6%) had a formal education. Table 1 shows religious affiliation (most of the sample was Catholic), marital status, and, crucially, income.
The range of income is 2000 reals, and the median income across the participants was 400 reals per month (approximate exchange rate of 5 reals = UK £1). The official minimum salary in Brazil is 260 reals per month (in 2004), and 29 of the 82 (35.4%) respondents to this question earned at or below this level. The median family income was 520 reals.
The time since diagnosis ranged from 1 month to 6 years, with a median of 18 months. Twenty-two participants (24.7%) were in palliative care, 37 (41.6%) were in follow-up, 4 (4.5%) were under initial investigation, and the remainder were categorized as either being under treatment classified as curative (11, 12 .4%) or as adjuvante -an adjunct to, rather than central part of, disease management (15, 16.9%).
Use of TMs and CAMs
When looking at the immediate headline figure, the level of use of at least 1 form of TM or CAM appears to be high at just under two thirds (see Table 2 ), with a median of 1 therapy or practice used (range, 1-5; confidence interval [CI], 52.0%, 72.9%; for the category "other TM/CAM without prayer," CI, 9.8%, 26.3%). However, this is potentially misleading, and it is important to look beyond this to assess 2 things: (1) the difference between use levels for local TM versus nonindigenous CAM and (2) the precise nature of those therapies receiving reports of high levels of use.
On the first point, it is clear that the apparently high level of use is in fact restricted largely to traditional practices. Almost without exception, there was little or no use of nonindigenous globalized CAM by this group of service users. Aromatherapy, reflexology, use of crystals, Ayurveda, Chinese medicine, hydrotherapy, homeopathy, iridology, osteopathy, chiropractic, and even yoga were all unused by the respondents. And while a small number of people did report use of some other therapies (see Table 3 ), use levels remained negligible. Sixteen people (18%) did report using dietary change, but this all-embracing term included such a wide range of strategies that meaningful categorization was prevented; indeed, this included following mainstream hospital-based dietary advice.
As for the type of TM being used, 2 practices stood out. Twenty-one (23.6%) respondents reported using indigenous herbal treatments, while prayer was used by nearly half of the sample (41, 46.1%). Whether or not prayer can appropriately be classified as medicine/therapy is open to debate, and given the (international) nature of the religions of many participants (see Table 1 ), its traditional and/or local character is also in doubt. Clearly, accepting that this survey provides evidence of a high use rate depends on the inclusion of prayer. Participants were also asked whether they believed that scientific evidence existed for TM that they used. Interestingly, a large proportion of users did (14 of 21 for traditional herbal treatments, 35 of 41 for prayer).
Discussion
This article reports findings from the first exploratory study of TM and CAM use among low-income cancer service users in Brazil. It was developed in the context of the greater visibility of nonbiomedical practice for cancer care in poorer countries at the policy level, and academic uncertainty about the extent to which those CAMs are ubiquitous throughout the West are beginning to affect disease management elsewhere.
The results are quite clear in relation to the globalization of CAM. In this low-income sample, there is no evidence of the importation of new practices. Given the nature of the study, we are unable to assess whether this is a consequence of social and cultural processes, something grounded in conscious decision making, or, rather more simply, a reflection of service availability and, of course, cost. In Brazil, as is still the norm throughout the world, CAM provision is essentially private, and few if any of our sample would be in a position to buy therapies. We should underline that we are not suggesting that CAMs have not spread to Brazil. As a country marked by substantial inequalities, patterns of use elsewhere are likely to be significantly different. A degree of caution is required when interpreting the results concerning use of TM. It is in the nature of survey data that we are unable to fully explore the individual and social meanings behind particular results. And it is perhaps the case that the prominence of prayer raises more questions than it answers. From the study, we simply do not know whether participants were referring to practices within formal international religions, whether or not more locally specific practices are involved, and if and how these may relate to particular belief systems. Similarly, until further work examines such issues, it would be premature to make conclusions about the extent of TM use.
This initial study has a number of limitations. It was designed to be the first phase of an ongoing exploration of cancer patients' practices in Brazil and should therefore not be used to seek definitive conclusions. The work is small scale. There was a male bias in the sample, with, for instance, many breast cancer patients excluded from the sample. And the sample was restricted to low-income patients and was regionally specific.
Both the nature of the study and the results that it provided point to a range of future research options (which the team is already actively developing). First, larger scale quantitative studies focusing on lowincome groups both within the same area of the country and in different regions are needed to examine both the trends relating to TM use and the potential incorporation of globalized CAM. Second, and crucially, we need in-depth qualitative work to uncover the processes behind such results. And third, work needs to be extended to other socioeconomic groups to explore the interconnections between the use of specific therapeutic options and conceptions of self, identity, and social differentiation.
Finally, while this initial study has provided no evidence of the incorporation of nontraditional CAM by this group of patients, it is important that as we study therapeutic strategies in poorer countries, we are aware of the increasing range of options that now exist and the potential for the unequal incorporation of them. In approaching the study of health practice, we need to explore not only biomedicine and TM but also the potential influence of alternatives that have originated elsewhere in (frequently poor parts of ) the world that have been appropriated by, and filtered through, the West. It will be important over the coming period to study if and how the full range of therapeutic alternatives is impinging on cancer care in poorer countries.
